Doravirine

Trade Name: 
Pifeltro
Manufacturer/Distributor: 
Merck Canada Inc.
merck.ca
Classification: 
NNRTI
ATC Class: 
J05AG: Non-nucleoside reverse transcriptase inhibitor
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2018/10/12
Date Marketed in Canada (yyyy/mm/dd): 
2018/11/15
Presentation: 
Tablet: 100 mg. DIN: 02481545
Comments: 
Antiviral agent for treatment of HIV-1.
Source: 
Produce monograph; letter from company